ARCHIVES

Two Studies Demonstrate Molecule Blocking Cell Damage

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

Volasertib and LDAC Doubled Response in Older Patients

July 25, 2014

Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma

January 30, 2009

Three Nominated To ET2; NCI Seeks Clinical Applications

May 24, 1991

Letter: The Lesson From Dana-Farber

July 28, 1995

Phase II Study Tests Chemo Plus Mylotarg For AML

December 27, 2002

Patient Advocacy: Breast Cancer Coalition Forms PAC To Increase Political Activities

April 18, 1997